AGNG

Aging Population ETF

Overview Prices & Performance Holdings & Characteristics Research Documents

Reasons to Consider AGNG

High Growth Potential

AGNG enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

AGNG's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, AGNG delivers access to dozens of companies with high exposure to the Longevity theme.

Key Information As of 11/30/21

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$59.76 million
NAV	$27.41
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 11/30/21

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	2,180,000
Number of Holdings	100
30-Day Median Bid-Ask Spread	0.26%

Distributions As of 11/30/21

30-Day SEC Yield	0.74%
Distribution Frequency	Semi-Annually

ETF Prices As of 11/30/21

NAV	$27.41	Daily Change	-$0.48	-1.72%
Market Price	$27.49	Daily Change	-$0.43	-1.53%

As of recent (09/30/21) As of recent (09/30/21)	Fund NAV	Market Price	Index
1 Year	14.19%	13.41%	14.43%
3 Years	10.02%	9.59%	10.23%
5 Years	13.06%	12.84%	13.35%
Since Inception	13.65%	13.94%	13.94%
1 Year	21.06%	21.24%	21.31%
3 Years	15.61%	15.48%	15.86%
5 Years	15.48%	15.46%	15.78%
Since Inception	13.69%	14.14%	13.98%
Year-to-Date	4.36%	3.98%	4.48%
1 Month	-5.47%	-6.39%	-5.48%
3 Months	-4.17%	-5.01%	-4.18%
Since Inception	99.35%	102.09%	102.28%
Year-to-Date	5.69%	6.14%	5.84%
1 Month	1.27%	2.07%	1.31%
3 Months	-2.76%	-2.98%	-2.72%
Since Inception	101.87%	106.27%	104.92%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
4.79	NOVOB DC	NOVO NORDISK A/S-B	BHC8X90	106.66	26,828	2,861,398.88
4.23	LLY	ELI LILLY & CO	2516152	248.04	10,181	2,525,295.24
4.16	REGN	REGENERON PHARMACEUTICALS	2730190	636.53	3,903	2,484,376.59
3.96	EW	EDWARDS LIFESCIENCES CORP	2567116	107.31	22,063	2,367,580.53
3.68	RO SW	ROCHE HOLDING AG-BR	7108918	412.79	5,327	2,198,956.13
3.44	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	54.83	37,535	2,058,044.05
3.38	ABBV	ABBVIE INC	B92SR70	115.28	17,494	2,016,708.32
3.30	DXCM	DEXCOM INC	B0796X4	562.59	3,506	1,972,440.54
3.05	BSX	BOSTON SCIENTIFIC CORP	2113434	38.07	47,923	1,824,428.61
2.97	JNJ	JOHNSON & JOHNSON	2475833	155.93	11,384	1,775,107.12
2.94	SYK	STRYKER CORP	2853688	236.63	7,430	1,758,160.90
2.74	MDT	MEDTRONIC PLC	BTN1Y11	106.70	15,364	1,639,338.80
2.69	BMY	BRISTOL-MYERS SQUIBB CO	2126335	53.63	29,971	1,607,344.73
2.52	4519 JP	CHUGAI PHARMA CO	6196408	32.41	46,480	1,506,419.48
2.51	AMGN	AMGEN INC	2023607	198.88	7,532	1,497,964.16
2.39	ALC SW	ALCON INC	BJT1GR5	78.58	18,143	1,425,717.48
2.17	BIIB	BIOGEN INC	2455965	235.74	5,507	1,298,220.18
2.06	STMN SW	STRAUMANN HOLDING AG-REG	7156832	2,114.76	582	1,230,791.01
2.02	WELL	WELLTOWER INC	BYVYHH4	79.62	15,140	1,205,446.80
1.93	BGNE	BEIGENE LTD-ADR	BYYWPW6	347.53	3,317	1,152,757.01
1.89	4543 JP	TERUMO CORP	6885074	40.76	27,645	1,126,787.26
1.77	4503 JP	ASTELLAS PHARMA INC	6985383	15.67	67,657	1,060,334.07
1.76	SGEN	SEAGEN INC	BLPK4D2	160.00	6,585	1,053,600.00
1.53	GMAB DC	GENMAB A/S	4595739	384.13	2,386	916,532.54
1.52	ZBH	ZIMMER BIOMET HO	2783815	119.60	7,593	908,122.80
1.47	SOON SW	SONOVA HOLDING AG-REG	7156036	374.43	2,341	876,546.90
1.46	068270 KS	CELLTRION INC	B0C5YV1	174.26	5,008	872,679.52
1.28	UCB BB	UCB SA	5596991	108.21	7,079	766,051.03
1.16	PODD	INSULET CORP	B1XGNW4	288.44	2,408	694,563.52
1.06	FME GR	FRESENIUS MEDICA	5129074	59.41	10,687	634,902.25
1.06	VTR	VENTAS INC	2927925	46.92	13,521	634,405.32
0.91	INCY	INCYTE CORP	2471950	67.72	8,027	543,588.44
0.88	EXAS	EXACT SCIENCES CORP	2719951	85.37	6,168	526,562.16
0.86	ABMD	ABIOMED INC	2003698	314.78	1,641	516,553.98
0.85	SN/ LN	SMITH & NEPHEW PLC	0922320	16.11	31,497	507,337.30
0.84	TFX	TELEFLEX INC	2881407	297.42	1,692	503,234.64
0.73	3692 HK	HANSOH PHARMACEU	BJYKB72	2.04	214,000	437,012.00
0.69	DEMANT DC	DEMANT A/S	BZ01RF1	47.48	8,641	410,264.89
0.66	AMP IM	AMPLIFON SPA	B14NJ71	48.54	8,153	395,710.77
0.62	DVA	DAVITA INC	2898087	94.50	3,948	373,086.00
0.61	COH AU	COCHLEAR LTD	6211798	154.43	2,358	364,147.94
0.58	NVCR	NOVOCURE LTD	BYSS4X4	93.64	3,678	344,407.92
0.52	UTHR	UNITED THERAPEUTICS CORP	2430412	189.50	1,633	309,453.50
0.49	GN DC	GN STORE NORD A/S	4501093	57.06	5,134	292,942.95
0.47	NBIX	NEUROCRINE BIOSC	2623911	83.25	3,385	281,801.25
0.45	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	4.18	64,900	271,393.11
0.40	OHI	OMEGA HEALTHCARE	2043274	27.94	8,532	238,384.08
0.37	ORP FP	ORPEA	7339451	93.87	2,327	218,446.01
0.34	AED BB	AEDIFICA	B1G5XP1	133.05	1,514	201,430.40
0.34	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	96.20	2,089	200,961.80
0.33	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.54	368,100	199,729.73
0.33	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	46.26	4,306	199,195.56
0.33	ALEC	ALECTOR INC	BJ4LDC4	20.65	9,624	198,735.60
0.33	MNKD	MANNKIND CORP	BF081J4	4.63	42,151	195,159.13
0.32	ANGO	ANGIODYNAMICS INC	B00CR04	25.75	7,519	193,614.25
0.32	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	62.86	3,027	190,277.22
0.31	EXEL	EXELIXIS INC	2576941	16.79	11,144	187,107.76
0.31	LIVN	LIVANOVA PLC	BYMT0J1	80.16	2,304	184,688.64
0.29	1858 HK	BEIJING CHUNLI-H	BVVPXP6	2.36	73,900	174,041.83
0.29	4547 JP	KISSEI PHARM CO	6494061	20.12	8,560	172,187.59
0.28	AMED	AMEDISYS INC	2024332	139.65	1,215	169,674.75
0.28	HALO	HALOZYME THERAPEUTICS INC	2975098	32.88	5,153	169,430.64
0.28	ACAD	ACADIA PHARMACEU	2713317	19.20	8,797	168,902.40
0.27	CSH-U CN	CHARTWELL RETIRE	B8S8C94	8.60	18,614	160,050.22
0.26	ITGR	INTEGER HOLDINGS CORP	BD06LM7	79.74	1,976	157,566.24
0.26	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	11.79	13,287	156,594.12
0.26	NHC	NATIONAL HEALTHCARE CORP	2139731	64.49	2,388	154,002.12
0.26	8086 JP	NIPRO CORP	6641599	9.47	16,170	153,091.29
0.26	BKD	BROOKDALE SR	B0PZN33	5.86	26,075	152,799.50
0.25	RDUS	RADIUS HEALTH INC	BM68KK1	16.46	9,173	150,987.58
0.25	ARNA	ARENA PHARMACEUTICALS INC	BF3N4P3	54.49	2,754	150,065.46
0.25	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	76.33	1,953	149,072.49
0.25	RYM NZ	RYMAN HEALTHCARE LTD	6161525	8.35	17,776	148,393.73
0.25	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	40.58	3,653	148,238.74
0.24	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.46	315,347	144,813.24
0.24	KORI FP	KORIAN	B1HKRM0	29.40	4,777	140,446.23
0.22	LTC	LTC PROPERTIES INC	2498788	31.76	4,143	131,581.68
0.22	NUVA	NUVASIVE INC	B00GJC2	48.06	2,727	131,059.62
0.21	LHCG	LHC GROUP INC	B06DT50	114.72	1,115	127,912.80
0.21	SBRA	SABRA HEALTH CAR	B5NLBP6	12.93	9,846	127,308.78
0.21	NHI	NATL HEALTH INVESTORS INC	2626125	52.24	2,411	125,950.64
0.21	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	35.62	3,437	122,425.94
0.20	FGEN	FIBROGEN INC	BSDRYR8	12.51	9,666	120,921.66
0.20	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	11.10	10,479	116,316.90
0.19	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	0.86	131,800	113,104.02
0.18	AMRN	AMARIN CORP PLC -ADR	2301938	3.60	30,293	109,054.80
0.18	2500 HK	VENUS MEDTECH -H	BL6V047	4.96	21,400	106,233.44
0.18	INGN	INOGEN INC	BJSVLL5	30.55	3,461	105,733.55
0.18	DHC	DIVERSIFIED HEAL	BKRN595	2.79	37,760	105,350.40
0.17	PHM SM	PHARMA MAR SA	BMW2GT8	64.50	1,548	99,840.62
0.17	HRTX	HERON THERAPEUTICS INC	BJ0XLZ3	9.45	10,527	99,480.15
0.16	AERI	AERIE PHARMACEUTICALS INC	BFRTDG1	10.10	9,603	96,990.30
0.15	GKOS	GLAUKOS CORP	BYMWL19	43.03	2,144	92,256.32
0.14	PNTG	PENNANT GROUP INC/THE	BKTC976	20.33	4,114	83,637.62
0.14		CASH		1.00	82,779	82,788.23
0.12	OMER	OMEROS CORP	B4NB858	7.20	10,283	74,037.60
0.12	EPZM	EPIZYME INC	B9Z1QZ7	3.27	21,616	70,684.32
0.12	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	8.40	8,357	70,198.80
0.11	TCMD	TACTILE SYSTEMS	BZB1XF2	19.50	3,484	67,938.00
0.11	BLUE	BLUEBIRD BIO INC	BBFL7S1	10.11	6,275	63,440.25
0.09	TSVT	2SEVENTY BIO INC	BMTXV88	26.34	2,093	55,129.62

Holdings are subject to change.

Sector Breakdown As of 10/31/21

	Sector	Weight (%)
	Health Care	94.1
	Real Estate	4.8
	Information Technology	0.5
	Industrials	0.3
	Communication Services	0.3

Source: AltaVista Research, LLC

Country Breakdown As of 10/31/21

	Country	Weight (%)
	United States	56.9
	Switzerland	9.3
	Denmark	7.4
	Japan	6.9
	Britain	5.3
	China	4.2
	Ireland	3.1
	Belgium	1.6
	South Korea	1.3
	Germany	1.1
	Italy	0.6
	Other/Cash	2.3

Source: AltaVista Research, LLC

ETF Characteristics As of 11/30/21

Return on Equity	15.40%
Weighted Avg. Market Cap	88,553 M
	2020	2021
Price-to-earnings	30.44	25.07
Price-to-book value	4.07	3.69

Source: AltaVista Research, LLC

ETF Risk Stats As of 11/30/21

Versus	Beta
S&P 500	0.77
MSCI EAFE	0.78
MSCI Emg. Mkts	0.63
Standard Deviation	17.70%

Source: AltaVista Research, LLC

ETF Research

Preparing for an Aging World

Thematic Investing Whitepaper

More Thematic Research...

Latest Premium / Discount As of 11/30/21

NAV	$27.41
Market Price	$27.49
Premium / (Discount)	$0.08

Current View 2021 Q4 As of 11/30/21

Days at Premium	36
Days at NAV	0
Days at Discount	6
Greatest Premium	1.00%
Greatest Discount	-0.48%

Daily Premium / Discount History As of 11/30/21

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

High Growth Potential

Unconstrained Approach

ETF Efficiency

Key Information As of 11/30/21

ETF Summary

ETF Objective

Trading Details As of 11/30/21

Distributions As of 11/30/21

ETF Prices As of 11/30/21

Performance History

Top Holdings As of 11/30/21

Sector Breakdown As of 10/31/21

Country Breakdown As of 10/31/21

ETF Characteristics As of 11/30/21

ETF Risk Stats As of 11/30/21

ETF Research

Preparing for an Aging World

Thematic Investing Whitepaper

More Thematic Research...

ETF Documents